VLKIM
VIVO

Van Lanschot Kempen Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,333,091
Closed -$40.6M – 225
2022
Q2 		$40.6M Sell
1,333,091
-211,163
-14% -$5.71M 1.46% 21
2022
Q1 		$40.1M Buy
1,544,254
+174,907
+13% +$4.16M 1.22% 25
2021
Q4 		$27.9M Buy
1,369,347
+818,144
+148% +$15.7M 0.86% 36
2021
Q3 		$10.6M Buy
551,203
+136,880
+33% +$2.73M 0.38% 86
2021
Q2 		$9.19M Buy
+414,323
New +$8.79M 0.33% 89

Other funds holding VIVO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return